The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot study of CBX-12 pharmacodynamics in patients with advanced solid tumors.
 
Sarah Shin
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
Travel, Accommodations, Expenses - Novartis Ireland Ltd.
 
Larry V. Rubinstein
No Relationships to Disclose
 
Naoko Takebe
No Relationships to Disclose
 
John Joseph Wright
No Relationships to Disclose
 
Deborah Wilsker
No Relationships to Disclose
 
Katherine V. Ferry-Galow
No Relationships to Disclose
 
Chris Alan Karlovich
Stock and Other Ownership Interests - Clovis Oncology
Research Funding - Illumina (Inst)
(OPTIONAL) Uncompensated Relationships - Illumina
 
Larry Anderson
No Relationships to Disclose
 
Laura Kuhlmann
No Relationships to Disclose
 
Ralph E. Parchment
Employment - Leidos Biomedical Research
Stock and Other Ownership Interests - Inovio Pharmaceuticals; Leidos; SciTech Development LLC
Patents, Royalties, Other Intellectual Property - Cambridge University Press for The Biological Basis of Cancer; named inventor on EU patent EP3430051B1; Named Inventor on US Patent 9,644,037; Named inventor on US Patent US8709379 B2
 
James H. Doroshow
No Relationships to Disclose
 
Alice P. Chen
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)